Trials / Conditions / Mild to Moderate Psoriasis
Mild to Moderate Psoriasis
7 registered clinical trials studyying Mild to Moderate Psoriasis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis. NCT05965089 | Arxx Therapeutics | Phase 1 |
| Unknown | A Phase III Study in Subjects With Mild to Moderate Psoriasis. NCT05249972 | Lipidor AB | Phase 3 |
| Terminated | Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis NCT03222622 | Betta Pharmaceuticals Co., Ltd. | Phase 2 |
| Completed | A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis NCT02529956 | UCB Celltech | Phase 1 |
| Completed | Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) NCT01587755 | Kristian Reich, MD | Phase 4 |
| Withdrawn | Topical Application of AS101 for the Treatment of Psoriasis NCT00788424 | BioMAS Ltd | Phase 2 |
| Completed | Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis NCT01000714 | Etwal Ltd. | Phase 2 |